Compare ANIP & TNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANIP | TNK |
|---|---|---|
| Founded | 2001 | 2007 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 2.7B |
| IPO Year | 1999 | 2007 |
| Metric | ANIP | TNK |
|---|---|---|
| Price | $73.27 | $66.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | ★ $107.33 | $77.00 |
| AVG Volume (30 Days) | 302.6K | ★ 556.2K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.88% |
| EPS Growth | ★ 419.23 | N/A |
| EPS | ★ 3.32 | N/A |
| Revenue | ★ $206,547,000.00 | N/A |
| Revenue This Year | $19.88 | N/A |
| Revenue Next Year | $15.77 | N/A |
| P/E Ratio | $22.98 | ★ $8.05 |
| Revenue Growth | ★ 2.47 | N/A |
| 52 Week Low | $56.71 | $33.35 |
| 52 Week High | $99.50 | $82.24 |
| Indicator | ANIP | TNK |
|---|---|---|
| Relative Strength Index (RSI) | 37.63 | 40.54 |
| Support Level | $62.89 | $42.26 |
| Resistance Level | $85.12 | $82.24 |
| Average True Range (ATR) | 2.72 | 2.98 |
| MACD | -0.02 | -1.37 |
| Stochastic Oscillator | 6.29 | 0.99 |
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
Teekay Tankers Ltd is a provider of marine services to the international oil and natural gas industries and an operator of medium-sized oil tankers. The company operates in two segments: Tankers, which consists of the operation of all of the company's tankers (including the operations from those tankers employed on full service lightering contracts), and the company's U.S. based ship-to-ship support service operations (including its lightering support services provided as part of full service lightering operations); and Marine Services, which consists of operational and maintenance marine services provided to the Australian government, Australian energy companies and other third parties. The company generates the majority of its revenue from the Tankers segment.